NAOV

NanoVibronix Inc
0.305
0.0001 (0.03%)
Company Name Stock Ticker Symbol Market Type
NanoVibronix Inc NAOV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0001 0.03% 0.305 19:56:46
Open Price Low Price High Price Close Price Prev Close
0.3024 0.3001 0.3168 0.3086 0.3049
more quote information »

Recent News

Date Time Source Heading
1/31/20237:30IHNWFeaturedAmerican Green (OTC:ERBB) Quarterly Cannabis Cultivation Revenue Increased 69% over the same period last year.
1/18/202308:30BWNanoVibronix Provides Update on Expanding Access to..
1/05/202316:07EDGARStatement of Changes in Beneficial Ownership (4)
12/15/202217:31EDGARCurrent Report Filing (8-k)
12/15/202216:05BWNanoVibronix Announces Results of Annual Meeting of..
12/13/202208:30BWNanoVibronix Announces Partnership with Peak Medical, Ltd.
12/01/202214:06BWNanoVibronix Announces Closing of $2.4 Million Registered..
12/01/202206:12EDGARCurrent Report Filing (8-k)
11/29/202208:07BWNanoVibronix Announces $2.4 Million Registered Direct..
11/28/202215:18BWNanoVibronix Receives FDA 510(k) Premarket Clearance for..
11/16/202208:31EDGARCurrent Report Filing (8-k)
11/16/202208:30BWNanoVibronix Announces Interim Results of Clinical Study for..
11/15/202208:33BWNanoVibronix Provides Business Update in Letter to..
10/31/202208:20EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/31/202208:16EDGARProxy Statement (definitive) (def 14a)
10/19/202208:31EDGARCurrent Report Filing (8-k)
10/19/202208:30BWNanoVibronix Receives Extension to Satisfy Nasdaq Price..
10/13/202211:15EDGARProxy Statement - Notice of Shareholders Meeting..
9/23/202208:31EDGARCurrent Report Filing (8-k)
9/23/202208:30BWNanoVibronix UroShield Approved for Sale through NHS..
9/15/202209:32EDGARCurrent Report Filing (8-k)
9/14/202216:05BWNanoVibronix Sets Date for Annual Shareholder Meeting
9/14/202210:22EDGARCurrent Report Filing (8-k)
9/14/202209:48EDGARSecurities Registration (section 12(g)) (8-a12g)
9/14/202209:25BWNanoVibronix Announces Distribution of Series F Preferred..
9/02/202216:31EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
9/02/202216:31EDGARCurrent Report Filing (8-k)
9/02/202216:31EDGARCurrent Report Filing (8-k)
9/02/202216:30BWNanoVibronix Announces Receipt of Nasdaq Listing..
8/18/202211:30BWNanoVibronix Provides Business Update in Letter to..
8/15/202218:17EDGARQuarterly Report (10-q)
7/15/202216:06EDGARProxy Statement - Notice of Shareholders Meeting..
7/12/202208:30BWNanoVibronix Announces Webinar Series to Promote UroShield
6/29/202217:14EDGARSmall Company Offering and Sale of Securities Without..
6/29/202208:30BWNanoVibronix Strengthening Supply Chain Increasing..
6/17/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
5/17/202208:31EDGARCurrent Report Filing (8-k)
5/17/202208:30BWNanoVibronix Reports First Quarter 2022 Financial Results
5/16/202218:16EDGARQuarterly Report (10-q)
5/04/202208:30BWNanoVibronix Announces FDA 510(k) Submission for PainShield®..
4/25/202208:30BWNanoVibronix Adds Additional Product to Federal Supply..
4/15/202206:33EDGARAnnual Report (10-k)
4/05/202208:30BWNanoVibronix Advances Efforts to Achieve NHS Approval
3/30/202209:35SEEKNanoVibronix stock soars 32% as Health Canada approves..
3/30/202208:30BWNanoVibronix Announces PainGuard and UroGuard Approved by..
3/02/202216:20EDGARCurrent Report Filing (8-k)
2/07/202208:30BWNanoVibronix Added an Additional National Payer Network in..